Why This Pharma Surged After Trump's Opioid Declaration
Opiant Pharmaceuticals spiked 46 percent Thursday when President Donald Trump declared a crackdown on opioid abuse. Source: BioSpace
Opiant Pharmaceuticals spiked 46 percent Thursday when President Donald Trump declared a crackdown on opioid abuse. Source: BioSpace
Wave Life Sciences has officially opened a new state-of-the art manufacturing facility to support advancement of the company’s stereopure nucleic acid platform. Source: BioSpace
Once again Insys has been rocked by an indictment. Source: BioSpace
Gilead continues to see serious revenue declines in its hepatitis C marketshare, a space it has dominated for several years. Source: BioSpace
New positions have been announced at Regeneron as the company’s Irish bioprocessing campus receives an additional $100m in funding. Source: BioSpace
Versartis has retained Cowen to assist in evaluating its strategic options. Source: BioSpace
A venture of Anhui Chem Bright Bioengineering Co. Ltd. named KB Biotech Solutions, is opening a manufacturing facility in Dillon County, SC. Source: BioSpace
With pending regulatory approval for its topical pain medication for the eye, analysts are taking a fond look at Kala Pharmaceuticals. Source: BioSpace
Kitov announced today that its randomized double-blind, placebo-controlled renal function clinical trial for its lead drug candidate, KIT-302, successfully met its primary efficacy endpoint. Source: BioSpace
One of the growing areas in the medical device industry is new approaches to drug delivery. Source: BioSpace